Novi vs Willow: Which GLP-1 Provider Is Better?
By Iacob Pastina, Independent Researcher
Willow beats Novi overall, scoring 8.2/10 vs 7.8/10. Novi is more affordable at $133/mo vs $299/mo. Choose Novi for cash-pay patients who want compounded semaglutide or tirzepa. Choose Willow for users who want comprehensive clinical support with flexibili.
A side-by-side comparison of Novi and Willow covering pricing, scores, medication types, insurance, and more to help you decide.
Novi
#14 of 46Telehealth platform for compounded semaglutide and tirzepatide with month-to-month billing, six named clinicians on staff, and a 3-minute pre-approval quiz. Novi emphasizes 'all-in transparent' pricing — medication, supplies, unlimited clinician check-ins, dose adjustments, and weight-loss coaching are bundled with no add-on fees. Standard pricing is $174/mo semaglutide and $283/mo tirzepatide; promotional pricing on the offer landing drops to $99-$133/mo semaglutide and $149-$166/mo tirzepatide with $200 off advertised.
Visit NoviWillow
#8 of 46Personalized GLP-1 weight loss with ongoing clinical support. Compounded semaglutide and tirzepatide only — Willow explicitly does not prescribe brand-name Wegovy or Zepbound. Added oral compounded semaglutide tablets as a non-injectable option.
Visit Willow| Feature | Novi | Willow |
|---|---|---|
| Our Score | 7.8/10 | 8.2/10 |
| Starting Price | $133/mo | $299/mo |
| Medication Type | Compounded | Compounded |
| Insurance Accepted | No | No |
| Best For | Cash-pay patients who want compounded semaglutide or tirzepatide on a no-commitment plan with named clinicians, unlimited check-ins, and aggressive promotional pricing as low as $99-$133/mo on the introductory offer | Users who want comprehensive clinical support with flexibility between injectable and oral compounded semaglutide routes |
| Ranking | #14 | #8 |
Pros & Cons Compared
Novi
Pros
- +Six disclosed clinicians on staff — Daniel Funsch MD, Michael Wasef MD, Takashi Nakamura MD plus three nurse practitioners (Hastings NP, Clements NP, Vergara DNP) — more named providers than most compounded-only platforms publish
- +Month-to-month billing with no minimum commitment — cancel before any renewal date with no early-termination penalty
- +Aggressive promotional pricing on the offer landing — $99-$133/mo compounded semaglutide and $149-$166/mo compounded tirzepatide with a $200 OFF intro discount
- +Unlimited clinician check-ins, dose adjustments, and weight-loss coaching included at no additional cost
- +Free 2-day shipping; same active ingredients as Wegovy/Ozempic and Mounjaro/Zepbound (semaglutide and tirzepatide respectively)
- +100,000+ patients claimed and editorial coverage in Bloomberg, Forbes, and WebMD provide third-party signal
Cons
- −Compounded-only — no FDA-approved Wegovy, Zepbound, Ozempic, or Mounjaro through the platform; no Foundayo or oral GLP-1 formats
- −Founding year, headquarters city, and corporate ownership are not publicly disclosed
- −Promotional $99-$133 pricing applies to the introductory offer landing only — standard rate after any qualifying intro period is $174-$283/mo (verify the renewal rate before enrolling)
- −Once medication is dispensed/shipped, prescriptions cannot be returned or refunded — typical for compounded telehealth but worth understanding
- −Lab requirements before prescribing are not disclosed on public pages — unclear whether baseline bloodwork is required
- −Multiple landing pages (offer-v4, offer-v6-low) show different headline prices, which can create pricing confusion before checkout
Willow
Pros
- +Includes monthly provider check-ins and dose adjustments at no extra cost
- +Offers both injectable AND oral compounded semaglutide — one of few platforms with a daily oral tablet option
- +$299/mo all-in for compounded semaglutide with monthly provider support
- +90%+ patient retention rate after 3 months per their published outcomes data
Cons
- −Compounded-only — no brand-name Wegovy or Zepbound through the platform
- −Tirzepatide pricing reaches $499-$524 at higher doses — starting dose is $399/mo
- −Cash-pay only — no insurance billing, though they provide superbills for FSA/HSA
- −Founded in 2024 — less track record than Ro or Hims, though growth has been fast
Our Verdict
Willow edges out Novi with a score of 8.2/10 vs 7.8/10. If budget is your priority, Novi starts at $133/mo compared to Willow's $299/mo. Choose Novi if you want: cash-pay patients who want compounded semaglutide or tirzepatide on a no-commitment plan with named clinicians, unlimited check-ins, and aggressive promotional pricing as low as $99-$133/mo on the introductory offer. Choose Willow if you want: users who want comprehensive clinical support with flexibility between injectable and oral compounded semaglutide routes.